136 related articles for article (PubMed ID: 9633934)
1. IL-1beta-induced monocyte chemoattractant protein-1 gene expression in endothelial cells is blocked by proteasome inhibitors.
Parry GC; Martin T; Felts KA; Cobb RR
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):934-40. PubMed ID: 9633934
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-kappa B.
Cobb RR; Felts KA; Parry GC; Mackman N
Eur J Immunol; 1996 Apr; 26(4):839-45. PubMed ID: 8625976
[TBL] [Abstract][Full Text] [Related]
3. Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells.
Rovin BH; Dickerson JA; Tan LC; Hebert CA
Kidney Int; 1995 Oct; 48(4):1263-71. PubMed ID: 8569088
[TBL] [Abstract][Full Text] [Related]
4. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.
Wang XC; Jobin C; Allen JB; Roberts WL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):477-86. PubMed ID: 9950608
[TBL] [Abstract][Full Text] [Related]
5. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1.
Martin T; Cardarelli PM; Parry GC; Felts KA; Cobb RR
Eur J Immunol; 1997 May; 27(5):1091-7. PubMed ID: 9174597
[TBL] [Abstract][Full Text] [Related]
6. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the proteasome in IL-1beta induced suppression of islets of Langerhans in the rat.
Sternesjö J; Karlsen AE; Sandler S
Ups J Med Sci; 2003; 108(1):37-50. PubMed ID: 12903836
[TBL] [Abstract][Full Text] [Related]
8. Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway.
Nakayama K; Furusu A; Xu Q; Konta T; Kitamura M
J Immunol; 2001 Aug; 167(3):1145-50. PubMed ID: 11466328
[TBL] [Abstract][Full Text] [Related]
9. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production.
Haas M; Page S; Page M; Neumann FJ; Marx N; Adam M; Ziegler-Heitbrock HW; Neumeier D; Brand K
J Leukoc Biol; 1998 Mar; 63(3):395-404. PubMed ID: 9500529
[TBL] [Abstract][Full Text] [Related]
10. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
[TBL] [Abstract][Full Text] [Related]
11. Induction of the gene encoding macrophage chemoattractant protein 1 by Orientia tsutsugamushi in human endothelial cells involves activation of transcription factor activator protein 1.
Cho NH; Seong SY; Huh MS; Kim NH; Choi MS; Kim IS
Infect Immun; 2002 Sep; 70(9):4841-50. PubMed ID: 12183528
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory gene transcription in human astrocytes exposed to hypoxia: roles of the nuclear factor-kappaB and autocrine stimulation.
Stanimirovic D; Zhang W; Howlett C; Lemieux P; Smith C
J Neuroimmunol; 2001 Oct; 119(2):365-76. PubMed ID: 11585641
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G
Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1.
Hipp MS; Urbich C; Mayer P; Wischhusen J; Weller M; Kracht M; Spyridopoulos I
Eur J Immunol; 2002 Aug; 32(8):2208-17. PubMed ID: 12209633
[TBL] [Abstract][Full Text] [Related]
15. A biphasic role of nuclear transcription factor (NF)-kappaB in the islet beta-cell apoptosis induced by interleukin (IL)-1beta.
Papaccio G; Graziano A; D'Aquino R; Valiante S; Naro F
J Cell Physiol; 2005 Jul; 204(1):124-30. PubMed ID: 15622524
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
Shen X; Tian Z; Holtzman MJ; Gao B
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
[TBL] [Abstract][Full Text] [Related]
17. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.
Lee SA; Fitzgerald SM; Huang SK; Li C; Chi DS; Milhorn DM; Krishnaswamy G
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):283-91. PubMed ID: 15191916
[TBL] [Abstract][Full Text] [Related]
18. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.
Hellerbrand C; Jobin C; Iimuro Y; Licato L; Sartor RB; Brenner DA
Hepatology; 1998 May; 27(5):1285-95. PubMed ID: 9581682
[TBL] [Abstract][Full Text] [Related]
20. Suppression of monocyte chemoattractant protein 1, but not IL-8, by alprazolam: effect of alprazolam on c-Rel/p65 and c-Rel/p50 binding to the monocyte chemoattractant protein 1 promoter region.
Oda T; Ueda A; Shimizu N; Handa H; Kasahara T
J Immunol; 2002 Sep; 169(6):3329-35. PubMed ID: 12218154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
